KAYLA JOHNSON: Open Payments
NPI 1578963179 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,965 in 143 payments from 18 companies in 2025. Trend: 2023 $1,842 · 2024 $1,751 · 2025 $2,965
Food & beverage: $2,888Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $520 |
| UCB, Inc. | 10 | $482 |
| PFIZER INC. | 21 | $428 |
| ABBVIE INC. | 29 | $283 |
| Regeneron Healthcare Solutions, Inc. | 8 | $229 |
| Novartis Pharmaceuticals Corporation | 21 | $214 |
| Incyte Corporation | 3 | $163 |
| E.R. Squibb & Sons, L.L.C. | 5 | $158 |
| Galderma Laboratories, L.P. | 9 | $137 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $76 |
Products named: TREMFYA, Bimzelx, CIBINQO, DUPIXENT, SKYRIZI, OPZELURA, Sotyktu, NEMLUVIO.
Industry payments across IN — which companies pay providers there.
